LABORATORY CONTROL OF CONTINUOUS INTRAVENOUS HEPARIN-THERAPY WITH HOWEL TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME A PROSPECTIVE, RANDOMIZED AND BLIND-STUDY

被引:2
作者
ALMAZAN, A
LOZANO, F
RAMOS, M
RODRIGUEZMORAN, M
GOMEZALONSO, A
机构
关键词
D O I
10.1177/000331978503600605
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:363 / 369
页数:7
相关论文
共 24 条
[1]  
A National Cooperative Study, 1973, CIRCULATION S2, V47, pII1
[2]   CONTROL AND MANAGEMENT OF HEPARIN-THERAPY IN VENOUS THROMBOEMBOLISM [J].
ALMAZAN, A ;
LOZANO, F ;
RAMOS, M ;
GOMEZALONSO, A .
VASCULAR SURGERY, 1983, 17 (01) :1-8
[3]  
ALMAZAN A, 1982, ANGIOLOGIE, V8, P1
[4]  
ALMAZAN A, 1981, INT VASCULAR S LONDO, P294
[5]  
Almazan Enriquez A, 1983, Angiologia, V35, P178
[6]   PRECISE MANAGEMENT OF HEPARIN THERAPY [J].
BADEN, JP ;
SONNENFIELD, M ;
FERLIC, RM ;
SELLERS, RD .
AMERICAN JOURNAL OF SURGERY, 1972, 124 (06) :777-779
[7]   PROSPECTIVE STUDY OF VALUE OF MONITORING HEPARIN TREATMENT WITH ACTIVATED PARTIAL THROMBOPLASTIN TIME [J].
BASU, D ;
CADE, J ;
GALLUS, A ;
HIRSH, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (07) :324-+
[8]  
BLAISDELL FW, 1978, SURGERY, V84, P822
[9]  
BOUNAMEAUX H, 1979, Thrombosis and Haemostasis, V42, P380
[10]  
BOYERO MR, 1982, ACTA CHIR CATAL, V3, P151